P

Perth Blood Institute | Perth, Australia

Research site
(Unclaimed)
Location
18 Prowse Street, Perth, Western Australia, Australia
Site insights

Top conditions

Venous Thrombosis (2 trials)

Pulmonary Embolism (2 trials)

Thromboembolism (2 trials)

Thrombosis (2 trials)

Embolism (2 trials)

Top treatments

Apixaban
Dalteparin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)

This is a Phase 3,multicenter, randomized, open-label, blinded endpoint evaluation study comparing the effect of abelacimab relative to apixaban on v...

Enrolling
Pulmonary Embolism
Venous Thromboembolism
Biological: Abelacimab
Drug: Apixaban

This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembol...

Enrolling
Pulmonary Embolism
Venous Thromboembolism
Biological: Abelacimab
Drug: Dalteparin

Trial sponsors

A

Anthos Therapeutics (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems